| For: | Jamali R, Razavizade M, Arj A, Aarabi MH. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease. World J Gastroenterol 2016; 22(21): 5096-5103 [PMID: 27275102 DOI: 10.3748/wjg.v22.i21.5096] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i21/5096.htm |
| Number | Citing Articles |
| 1 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Iron as a therapeutic target in chronic liver disease. World Journal of Gastroenterology 2023; 29(4): 616-655 doi: 10.3748/wjg.v29.i4.616
|
| 2 |
Timon Adolph, Christoph Grander, Felix Grabherr, Herbert Tilg. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions. International Journal of Molecular Sciences 2017; 18(8) doi: 10.3390/ijms18081649
|
| 3 |
Ethan Baratz, Olga Protchenko, Shyamalagauri Jadhav, Deliang Zhang, Pierre-Christian Violet, Samantha Grounds, Minoo Shakoury-Elizeh, Mark Levine, Caroline C. Philpott. Vitamin E Induces Liver Iron Depletion and Alters Iron Regulation in Mice. The Journal of Nutrition 2023; 153(7) doi: 10.1016/j.tjnut.2023.04.018
|
| 4 |
Bai Li, Li Fang, Enfa Zhao. Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease. Gastroenterology Research and Practice 2022; 2022 doi: 10.1155/2022/5259088
|
| 5 |
Chiara Mele, Graziano Grugni, Stefania Mai, Roberta Vietti, Gianluca Aimaretti, Massimo Scacchi, Paolo Marzullo. Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-03538-7
|
| 6 |
Chi Zhang, Nan Zhou, Ping Qiu, Yuming Fu, Zefa Liu, Hongxia Li, Xiangjun Yang, Lei Zhang. Serum C1q/TNF-related protein 9 is not related to nonalcoholic fatty liver disease. Cytokine 2018; 110 doi: 10.1016/j.cyto.2018.04.019
|
| 7 |
Barkin Ergun, Mehreen Ahmed, Djamel Lebeche. Resistin in Tissue Remodeling and Fibrosis: A New Frontier. Biomolecules 2026; 16(8) doi: 10.3390/biom16081108
|
| 8 |
Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne. Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function. Proceedings of the Nutrition Society 2022; 81(2) doi: 10.1017/S0029665121003815
|
| 9 |
Letícia BALTIERI, Elinton Adami CHAIM, Felipe David Mendonça CHAIM, Murillo Pimentel UTRINI, Martinho Antonio GESTIC, Everton CAZZO. CORRELATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE FEATURES AND LEVELS OF ADIPOKINES AND INFLAMMATORY CYTOKINES AMONG MORBIDLY OBESE INDIVIDUALS. Arquivos de Gastroenterologia 2018; 55(3) doi: 10.1590/s0004-2803.201800000-62
|
| 10 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9) doi: 10.3390/ijms22094495
|
| 11 |
Jessica Binetti, Laia Bertran, David Riesco, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jose Antonio Porras, Javier Camaron, Daniel Del Castillo, Cristóbal Richart, Teresa Auguet. Deregulated Serotonin Pathway in Women with Morbid Obesity and NAFLD. Life 2020; 10(10) doi: 10.3390/life10100245
|
| 12 |
Marianna G. Mavilia, George Y. Wu. Liver and serum adiponectin levels in non‐alcoholic fatty liver disease. Journal of Digestive Diseases 2021; 22(4) doi: 10.1111/1751-2980.12980
|
| 13 |
Dan Lv, Zepu Wang, Cuiqiao Meng, Yan Li, Shuai Ji. A study of the relationship between serum asprosin levels and MAFLD in a population undergoing physical examination. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62124-w
|
| 14 |
Rafael Bergesch D’Incao, Cristiane Valle Tovo, Vanessa Suñé Mattevi, Diego Olschowsky Borges, Jane Maria Ulbrich, Gabriela Perdomo Coral, Mauricio Jacques Ramos, Nelson Guardiola Meinhardt. Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. Obesity Surgery 2017; 27(8) doi: 10.1007/s11695-017-2627-4
|
| 15 |
Ricardo Rodríguez-Calvo, Sara Samino, Josefa Girona, Neus Martínez-Micaelo, Pere Ràfols, María García-Altares, Sandra Guaita-Esteruelas, Alexandra Junza, Mercedes Heras, Oscar Yanes, Xavier Correig, Lluis Masana. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms. Biomolecules 2020; 10(9) doi: 10.3390/biom10091275
|
| 16 |
Mitra Moodi, Tahmineh Tavakoli, Zoya Tahergorabi. Crossroad between Obesity and Gastrointestinal Cancers: A Review of Molecular Mechanisms and Interventions. International Journal of Preventive Medicine 2021; 12(1) doi: 10.4103/ijpvm.IJPVM_266_20
|
| 17 |
Driton Vela. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker. Molecular Medicine 2018; 24(1) doi: 10.1186/s10020-018-0008-7
|
| 18 |
Raika Jamali, Mehdi Ebrahimi, Ali Faryabi, Haleh Ashraf. Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?. Middle East Journal of Digestive Diseases 2020; 12(2) doi: 10.34172/mejdd.2020.168
|
| 19 |
I. Kasacka, Ż. Piotrowska, N. Domian, A. Lewandowska, M. Acewicz. Immunohistochemical identification and assessment of the location of leptin, visfatin and chemerin in the liver of men with different body mass index. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02299-6
|
| 20 |
Djuro Macut, Ivana Božić-Antić, Jelica Bjekić-Macut, Konstantinos Tziomalos. MANAGEMENT OF ENDOCRINE DISEASE: Polycystic ovary syndrome and nonalcoholic fatty liver disease. European Journal of Endocrinology 2017; 177(3) doi: 10.1530/EJE-16-1063
|
| 21 |
Miaomiao Jin, Xiaohong Niu, Yan Liu, Dong Zhang, Danni Yuan, Huimin Shen. Effect of glucagon-like peptide-1 receptor agonists on adipokine level of nonalcoholic fatty liver disease in rats fed high-fat diet. Open Medicine 2020; 15(1) doi: 10.1515/med-2020-0212
|
| 22 |
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2021; 10(14) doi: 10.3390/jcm10143029
|
| 23 |
Andrew Ndakotsu, Govinathan Vivekanandan. The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.25380
|
| 24 |
Chieh Chen. The role of adipokines in the disease of metabolic-associated fatty liver disease. Tungs' Medical Journal 2023; 17(2) doi: 10.4103/ETMJ.ETMJ-D-23-00015
|
| 25 |
Silvia Muller de Moura Sarmento, Gênifer Erminda Schreiner, Laura Smolski dos Santos, Camila Berny Pereira, Elizandra Gomes Schmitt, Vinicius Tejada Nunes, Rafael Tamborena Malheiros, Clóvis Klock, Chaline Casanova Petry, Itamar Luís Gonçalves, Vanusa Manfredini. Effect of Oral Vitamin D Overdose in Male and Female Wistar Rats with Induced MASLD. Livers 2025; 5(4) doi: 10.3390/livers5040052
|
| 26 |
N. R. Matkovska. CHANGES IN CARBOHYDRATE METABOLISM AND ADIPOCYTOKINES UNDER THE INFLUENCE OF TREATMENT OF PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER IN COMBINATION WITH OBESITY USING ADAMETHIONINUM AND ARGININE GLUTAMATE. Medical and Clinical Chemistry 2020; (3) doi: 10.11603/mcch.2410-681X.2020.v.i3.11514
|
| 27 |
C. Alejandra Monraz-Méndez, Rebeca Escutia-Gutiérrez, Jonathan Samael Rodriguez-Sanabria, Marina Galicia-Moreno, Hugo Christian Monroy-Ramírez, Laura Sánchez-Orozco, Jesus García-Bañuelos, Ricardo De la Rosa-Bibiano, Arturo Santos, Juan Armendáriz-Borunda, Ana Sandoval-Rodríguez. Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications. Nutrients 2022; 14(20) doi: 10.3390/nu14204225
|
| 28 |
V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, A. V. Tolmacheva. Hepcidin and MELD-XI score as markers of multiple organ failure in patients with heart failure with preserved and reduced ejection fraction. Cardiovascular Therapy and Prevention 2020; 19(3) doi: 10.15829/1728-8800-2020-2529
|
| 29 |
Nur Bengü Erdem, Evrim Kahramanoğlu Aksoy, Derya Dikmen, Kübra Uçar Baş, Aslihan Ağaçdiken, Merve İlhan Esgin, Zeynep Göktaş. Effects of low fat diet on inflammatory parameters in individuals with obesity/overweight and non-alcoholic fatty liver disease: A cross-sectional study. Medicine 2024; 103(15) doi: 10.1097/MD.0000000000037716
|
| 30 |
Jinzhou Zhu, Mingqing He, Yong Zhang, Tingxin Li, Yuping Liu, Zhiye Xu, Weichang Chen. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study. Endocrine Journal 2018; 65(3) doi: 10.1507/endocrj.EJ17-0466
|
| 31 |
V. I. Podzolkov, N. A. Dragomiretskaya, S. K. Stolbova, I. S. Rusinov. Associations of NT-proBNP and hepcidin levels with clinical and laboratory parameters in patients with heart failure with various severity of left ventricular systolic dysfunction. Cardiovascular Therapy and Prevention 2020; 19(4) doi: 10.15829/1728-8800-2020-2587
|
| 32 |
Johannes Bernhard, Lukas Galli, Walter S. Speidl, Konstantin A. Krychtiuk. Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis. Current Cardiology Reports 2025; 27(1) doi: 10.1007/s11886-024-02185-5
|
| 33 |
Mónica B. Jiménez-Castro, Araní Casillas-Ramírez, Elsa Negrete-Sánchez, Cindy G. Avalos-de León, Jordi Gracia-Sancho, Carmen Peralta. Adipocytokines in Steatotic Liver Surgery/Transplantation. Transplantation 2019; 103(1) doi: 10.1097/TP.0000000000002098
|
| 34 |
Eman M. Hasan, Rasha A. Abd Al Aziz, Dina Sabry, Hedy A. Badary, Yasmine Gaber, Ayman Yosry, Zeinab Zakaria. The association of adiponectin gene polymorphisms with susceptibility and progression of NAFLD in a cohort of Egyptian patients. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00103-w
|
| 35 |
Sujal Patel, Shilpa Bawankule, Sourya Acharya, Sunil Kumar. Cytokines and Inflammatory Markers in Nonalcoholic Fatty Liver Disease: A Narrative Review. Journal of the Scientific Society 2023; 50(3) doi: 10.4103/jss.jss_237_22
|
| 36 |
Chrysoula Boutari, Nikolaos Perakakis, Christos Socrates Mantzoros. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease. Endocrinology and Metabolism 2018; 33(1) doi: 10.3803/EnM.2018.33.1.33
|
| 37 |
Abdulrahman Ismaiel, Vera Ciornolutchii, Thelva Esposito Herrera, Mohamed Ismaiel, Daniel‐Corneliu Leucuta, Stefan‐Lucian Popa, Dan L. Dumitrascu. Adiponectin as a biomarker in liver cirrhosis—A systematic review and meta‐analysis. European Journal of Clinical Investigation 2025; 55(1) doi: 10.1111/eci.14328
|
| 38 |
CHANGES IN CARBOHYDRATE METABOLISM IN PATIENTS WITH ALCOHOLIC CIRRHOSIS OF THE LIVER ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE STAGE OF DECOMPENSATION. International Academy Journal Web of Scholar 2019; (6(36)) doi: 10.31435/rsglobal_wos/30062019/6551
|
| 39 |
Esra Akyüz Özkan, Allahverdi Sadigov, Osman Öztürk. Evaluation of Serum Omentin-1, Vaspin, Leptin, Adiponectin Levels in Obese/Overweight Children and Their Relationship With Non-Alcoholic Fatty Liver Disease. Clinical Nutrition Research 2022; 11(3) doi: 10.7762/cnr.2022.11.3.194
|
| 40 |
Christina Tontikidou, Evangelia S Makri, Kleo Evripidou, Dimitrios G Goulis, Antonis Goulas, Stergios A Polyzos. Circulating adiponectin in patients with nonalcoholic fatty liver disease‐related liver fibrosis: A systematic review and a meta‐analysis. Journal of Gastroenterology and Hepatology 2022; 37(10) doi: 10.1111/jgh.15926
|
| 41 |
Teresa Auguet, Laia Bertran, Jessica Binetti, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Jesús Miguel Lopez-Dupla, José Antonio Porras, David Riesco, Daniel Del Castillo, Cristóbal Richart. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences 2020; 21(11) doi: 10.3390/ijms21114189
|
| 42 |
Kristy L. Thomas, Callie L. Root, Jonathan M. Peterson, G. William Wong. Transgenic overexpression of CTRP3 does not prevent alcohol induced hepatic steatosis in female mice. PLOS ONE 2022; 17(1) doi: 10.1371/journal.pone.0258557
|
| 43 |
Liuhong Shen, Yingkun Zhu, Jinbang Xiao, Bolin Qian, Tao Jiang, Junliang Deng, Guangneng Peng, Shumin Yu, Suizhong Cao, Zhicai Zuo, Xiaoping Ma, Zhijun Zhong, Zhihua Ren, Ya Wang, Ziyao Zhou, Haifeng Liu, Xiaolan Zong, Yanchun Hu. Relationships between placental adiponectin, leptin, visfatin and resistin and birthweight in cattle. Reproduction, Fertility and Development 2020; 32(4) doi: 10.1071/RD18247
|
| 44 |
Mahdieh Nazari-Robati, Tania Dehesh, Beydolah Shahouzehi, Gholamreza Roshandel, Hossein Poustchi, Solaleh Emamgholipour, Aleksandra Klisic. Effects of a polypill on circulating levels of resistin and visfatin in men with non-alcoholic fatty liver disease: A five-year clinical trial. PLOS One 2025; 20(10) doi: 10.1371/journal.pone.0331121
|
| 45 |
Dongli Han, Jie Chen, Shousheng Liu, Zengzhi Zhang, Zhenzhen Zhao, Wenwen Jin, Yongning Xin. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2021.00018
|
| 46 |
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1) doi: 10.1210/endrev/bnz009
|
| 47 |
Nerma Čustović, Senija Rašić. Relationship of serum adiponectin and resistin levels with the severity of liver fibrosis in patients with chronic hepatitis B. Journal of Medical Biochemistry 2022; 41(2) doi: 10.5937/jomb0-33793
|
| 48 |
Raika Jamali, Soroush Veisi, Arsia Jamali, Mehdi Yaseri. Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-124229
|